Articolo
6 minuti di lettura
9 settembre 2026
COMUNITÀ E SALUTE GLOBALE
{{cartTotalQuantity}}
Menu di diagnostica molecolare
Strumenti e software
Le soluzioni di Cepheid
Accesso ai test ovunque
Utilizzo degli antibiotici
Cepheid’s Insights
Webinar
Cepheid RADAR
Support Center
Contatti
Informazioni su Cepheid
Missione e storia
Eventi
Distributori
Opportunità di sviluppo aziendale
Innovazione con Cepheid
Presentazione della moto Cepheid
Novità
La nostra leadership
Opportunità di lavoro
WHO EUL
Xpert® Hemorrhagic Fever Panel
When Clarity Matters Most.
Rapid Answers. Confident Action. No Compromise.
WHO EUL only. Potrebbe non essere disponibile in alcuni Paesi.
L’esigenza
La soluzione
L’impatto
Rapidly identify patients with suspected viral hemorrhagic fever
Support timely infection control and outbreak response
1. CDC. Screening and Evaluating an Ill Person for Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/diagnosis-testing/index.html
2. CDC. Infection Prevention and Control for Patients with Suspected or Confirmed Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html [ecdc.europa.eu]
3. WHO. Lassa Fever Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/lassa-fever [ijprems.com]
4. CDC. Lassa Fever Fact Sheet. https://stacks.cdc.gov/view/cdc/12236/cdc_12236_DS1.pdf [cdc.gov]
5. Organizzazione Mondiale della Sanità. Marburg virus disease - Equatorial Guinea and the United Republic of Tanzania. Disease Outbreak News, 8 maggio 2023. [who.int]
6. Centers for Disease Control and Prevention (CDC). History of Marburg Outbreaks. Updated 2025. [cdc.gov]
7. Organizzazione Mondiale della Sanità. Crimean-Congo hemorrhagic fever: Fact Sheet. Updated 20 febbraio 2025. [who.int]
8. UK Health Security Agency. Crimean-Congo hemorrhagic fever: origins, reservoirs, transmission and guidelines. Updated 2025. [gov.uk]
Xpert Hemorrhagic Fever Panel:
9. FDA 510(k) Decision Summary, Xpert® Hemorrhagic Fever Panel (K253653). Inactivation study results demonstrating viral inactivation during sample preparation are described in the submission documentation (see p. 23). Disponibile in: https://www.accessdata.fda.gov/cdrh_docs/reviews/K253653.pdf.
1. CDC. Screening and Evaluating an Ill Person for Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/diagnosis-testing/index.html
2. CDC. Infection Prevention and Control for Patients with Suspected or Confirmed Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html [ecdc.europa.eu]
Scheda tecnica
ENG
MSDS/SDS
ENG
MSDS/SDS
FRANCESE
Foglietto illustrativo
ENG
Cartridge Preparation
ENG
Articolo
6 minuti di lettura
9 settembre 2026
COMUNITÀ E SALUTE GLOBALE
Articolo
5 minuti di lettura
12 giugno 2026
COMUNITÀ E SALUTE GLOBALE